Saturn V Capital Management LLC Longboard Pharmaceuticals, Inc. Transaction History

Saturn V Capital Management LLC

  • $255 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$27.58 - $39.5 $1.1 Million - $1.58 Million
-39,913 Reduced 55.87%
31,529 $1.05 Billion
Q2 2024

Aug 14, 2024
BUY
$17.0 - $27.03 $1.21 Million - $1.93 Million
71,442 New
71,442 $1.93 Billion

Others Institutions Holding LBPH

# of Institutions
4
Shares Held
2.41M
Call Options Held
0
Put Options Held
0
View Full List

About Longboard Pharmaceuticals, Inc.

LBPH Quotes by TradingView
  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $815M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Saturn V Capital Management LLC Portfolio

Follow Saturn V Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Saturn V Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email